IL6 and systemic lupus erythematosus: Moreover, the SLE mice treated with anti-IL-33Ab, which has a protective effect on SLE, showed lower serum and renal levels of IL-1β, IL-6, and IL-17 than that in the untreated mice (Li et al., 2014b).